Quick Answer
Praxis Precision Medicines, Inc. reported Total Revenue of $0.00 for fiscal year 2025.
Praxis Precision Medicines, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $8.55M | +249.5% |
| 2023 | $2.45M | — |
| 2022 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | -100.0% | — |
| June 30, 2025 | $0.00 | -100.0% | — |
| March 31, 2025 | $0.00 | -100.0% | -100.0% |
| September 30, 2024 | $302.0K | -35.5% | -15.4% |
| June 30, 2024 | $357.0K | -54.3% | -17.2% |
| March 31, 2024 | $431.0K | -36.9% | -7.9% |
| September 30, 2023 | $468.0K | — | -40.1% |
| June 30, 2023 | $781.0K | — | +14.3% |
- Praxis Precision Medicines, Inc. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Praxis Precision Medicines, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: